Growth Metrics

Erasca (ERAS) Treasury Shares (2020 - 2022)

Erasca posted quarterly Treasury Shares of $38810.0 for Q2 2022, down 89.93% year-on-year from $385337.0 in Q2 2021, and down 67.6% on a QoQ basis from $119798.0 in Q1 2022.

Erasca (ERAS) has 3 years of Treasury Shares data on file, last reported at $38810.0 in Q2 2022.

  • For the quarter ending Q2 2022, Treasury Shares fell 89.93% year-over-year to $38810.0; the trailing twelve-month figure through Jun 2022 stood at $38810.0 (down 89.93% YoY), and the FY2021 full-year result was $212941.0, down 61.82% from the prior year.
  • Treasury Shares for Q2 2022 stood at $38810.0, down from $119798.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $557731.0 in Q4 2020 and bottomed at $38810.0 in Q2 2022.
  • The 3-year median for Treasury Shares is $256040.0 (2021), against an average of $268959.3.
  • The widest annual swing landed in 2021, when Treasury Shares plunged 61.82%; it then tumbled 89.93% in 2022.
  • A 3-year view of Treasury Shares shows it stood at $557731.0 in 2020, then slumped by 61.82% to $212941.0 in 2021, then sank by 81.77% to $38810.0 in 2022.
  • The last three Treasury Shares figures came in at $38810.0 (Q2 2022), $119798.0 (Q1 2022), and $212941.0 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 265,401.92
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 700,000.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 34.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Erasca 4.21 Bn 3.97 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 38,810.00
Jun 30, 2022 38,810.00
Mar 31, 2022 119,798.00
Mar 31, 2022 119,798.00
Dec 31, 2021 212,941.00
Dec 31, 2021 212,941.00
Sep 30, 2021 299,139.00
Sep 30, 2021 299,139.00
Jun 30, 2021 385,337.00
Jun 30, 2021 385,337.00
Dec 31, 2020 557,731.00
Dec 31, 2020 557,731.00